Eton Pharmaceuticals Inc (NAS:ETON)
$ 3.67 -0.03 (-0.81%) Market Cap: 94.28 Mil Enterprise Value: 82.39 Mil PE Ratio: 91.75 PB Ratio: 6.12 GF Score: 58/100

Q4 2021 Eton Pharmaceuticals Inc Earnings Call Transcript

Mar 16, 2022 / 11:00PM GMT
Release Date Price: $3.93
Operator

Good evening, and welcome to the Eton Pharmaceuticals fourth-quarter 2021 financial and operating results conference call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call up to your questions. Please be advised that this call is being recorded at the company's request.

At this time, I'd like to turn [the call] over to David Krempa, Senior Vice President of Business Development and Investor Relations at Eton Pharmaceuticals. Please proceed.

David Krempa
Eton Pharmaceuticals, Inc. - SVP, Business Development & IR

Thank you, operator. Good evening, everyone, and welcome to Eton's fourth-quarter 2021 conference call. This afternoon, we issued a press release that outlines the topics we plan to discuss on today's call. The release is available on our website, etonpharma.com.

Joining me on the call today, we have Sean Brynjelsen, our CEO; Wilson Troutman, our CFO; and Kevin Guthrie, our Executive Vice President of Commercial Activities.

In addition to taking live questions

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot